Internal Medicine, Nephrology · Tucson, AZ
NPI
1467600833
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
7370 N la Cholla Blvd
Tucson, AZ, 85741
Phone (520) 547-2468
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
2,447 services
Medicare patients, 2024
528
Average age 77
Drug cost, 2024
$844K
4,429 prescriptions
Company payments, 2025
$990
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anjuman A Howlader was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 820 times for 15 patients. In total Anjuman A Howlader billed 2,447 services in 20 codes, and Medicare paid $189K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-23.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 820 | 15 | $6.36 | $5,217 |
| 99215 Office E&M - Established | Office | 479 | 232 | $132.34 | $63K |
| 99233 Hospital E&M - Subsequent | Facility | 476 | 179 | $87.69 | $42K |
| 99214 Office E&M - Established | Office | 215 | 163 | $75.42 | $16K |
| 99223 Hospital E&M - Initial | Facility | 122 | 114 | $122.76 | $15K |
| 90960 ESRD Related Services (not dialysis) | Office | 84 | 16 | $259.85 | $22K |
| 90961 ESRD Related Services (not dialysis) | Office | 45 | 11 | $219.65 | $9,884 |
| 99291 Critical Care E&M | Facility | 35 | 17 | $161.44 | $5,650 |
| 99205 Office E&M - New | Office | 33 | 33 | $155.93 | $5,146 |
| 96372 Injection Administration | Office | 32 | 14 | $11.00 | $352 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 27 | $12.49 | $362 |
By year: 2022 $217K for 3,455 services; 2023 $192K for 2,664 services; 2024 $189K for 2,447 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anjuman A Howlader prescribed most often to Medicare patients was Allopurinol, with 773 prescriptions and refills. In total Anjuman A Howlader wrote 4,429 Medicare prescriptions that cost $844K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 773 | 2,218 | 210 | $9,143 |
| Amlodipine Besylate Generic | 372 | 1,021 | 109 | $2,511 |
| Furosemide Generic | 361 | 954 | 111 | $2,025 |
| Calcitriol Generic | 353 | 1,002 | 101 | $8,145 |
| Lisinopril Generic | 192 | 511 | 53 | $1,413 |
| Metoprolol Succinate Generic | 186 | 507 | 56 | $2,354 |
| Losartan Potassium Generic | 159 | 475 | 54 | $1,336 |
| Kerendia Finerenone | 156 | 298 | 37 | $190K |
| Potassium Chloride Generic | 138 | 361 | 42 | $15K |
| Hydralazine Hcl Generic | 136 | 360 | 43 | $1,902 |
| Tamsulosin Hcl Generic | 90 | 253 | 34 | $962 |
| Carvedilol Generic | 86 | 230 | 26 | $776 |
| Farxiga Dapagliflozin Propanediol | 85 | 163 | 24 | $88K |
| Telmisartan Generic | 83 | 239 | 24 | $1,616 |
| Spironolactone Generic | 81 | 219 | 23 | $1,354 |
Brand drugs: 612 claims; generic drugs: 3,817 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anjuman A Howlader $990 ($990 in general payments such as food, travel and fees) from 11 companies. The largest payer was OPKO Pharmaceuticals, LLC with $246.
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 13 | $246 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $138 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $99.39 |
| Calliditas Therapeutics US Inc. | 3 | $89.85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79.01 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $67.07 |
| Amgen Inc. AMGN | 3 | $64.21 |
| Fresenius USA Marketing, Inc. | 3 | $62.75 |
| Novo Nordisk Inc NVO | 2 | $60.99 |
| Ardelyx, Inc. ARDX | 2 | $43.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.